SCHEMBL58204

SCHEMBL58204

Oc1ccccc1-c1cccc(-c2cccc(-c3ccccc3O)n2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.48
SMN1; SMN2 Q16637 5/20 0.47
LMNA P02545 3/20 0.47
MAPT P10636 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
CASP3 P42574 2/20 0.47
SENP8 Q96LD8 2/20 0.47
SENP7 Q9BQF6 2/20 0.47
SENP6 Q9GZR1 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
RAB9A P51151 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPK10 P53779 1/20 0.47
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
HSD17B10 Q99714 2/20 0.46
BCL2L1 Q07817 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2542176 1.00 IDO1 (0.48) IDO1SMN1; SMN2LMNAMAPTTDP1
SCHEMBL6907528 0.98 IDO1 (0.50) IDO1SMN1; SMN2LMNAMAPTTDP1
Hydrochloric Acid SCHEMBL7235410 0.96 SMN1; SMN2 (0.46) IDO1SMN1; SMN2LMNAMAPTTDP1
SCHEMBL5106112 0.90 MEN1 (0.61) IDO1SMN1; SMN2LMNAMAPTTDP1
SCHEMBL5950612 0.88 SMN1; SMN2 (0.45) IDO1SMN1; SMN2LMNAMAPTTDP1
SCHEMBL4921855 0.88 KDM4E (0.67) IDO1SMN1; SMN2LMNATDP1CYP1A2
SCHEMBL7242146 0.88 IDO1 (0.44) IDO1SMN1; SMN2LMNAMAPTTDP1
SCHEMBL13810760 0.87 MEN1 (0.64) IDO1SMN1; SMN2LMNAMAPTTDP1
Lithium SCHEMBL29403726 0.87 KDM4E (0.64) IDO1SMN1; SMN2LMNATDP1CYP1A2
Acetic Acid SCHEMBL7768790 0.85 HSD17B14 (0.42) IDO1SMN1; SMN2LMNAMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3901235-B1 ORGANIC ELECTROLUMINESCENT DEVICES AND METAL COMPLEX COMPOUNDS UDC IRELAND LTD (IE) 2023-11-15 EP disclosed
EP-3211057-B2 ORGANIC ELECTROLUMINESCENT DEVICES AND METAL COMPLEX COMPOUNDS UDC IRELAND LTD (IE) 2022-11-02 EP disclosed
US-20220344601-A1 Organic Electroluminescent Devices and Metal Complex Compounds UDC IRELAND LTD (IE) 2022-10-27 US disclosed
US-11393989-B2 Organic electroluminescent devices and metal complex compounds UDC IRELAND LIMITED (IE) 2022-07-19 US disclosed
EP-3901235-A1 ORGANIC ELECTROLUMINESCENT DEVICES AND METAL COMPLEX COMPOUNDS UDC Ireland Limited (IE) 2021-10-27 EP disclosed
EP-3623444-B1 ORGANIC ELECTROLUMINESCENT DEVICES AND METAL COMPLEX COMPOUNDS UDC IRELAND LTD (IE) 2021-05-26 EP disclosed
EP-3623444-A1 ORGANIC ELECTROLUMINESCENT DEVICES AND METAL COMPLEX COMPOUNDS UDC Ireland Limited (IE) 2020-03-18 EP disclosed
US-20190355918-A1 Organic Electroluminescent Devices and Metal Complex Compounds UDC IRELAND LTD (IE) 2019-11-21 US disclosed
US-20190355918-A1 Organic Electroluminescent Devices and Metal Complex Compounds UDC IRELAND LTD (IE) 2019-11-21 US disclosed
US-10396299-B2 Organic electroluminescent devices and metal complex compounds UDC IRELAND LIMITED (IE) 2019-08-27 US disclosed
US-20060141285-A1 Organic electroluminescent device FUJI PHOTO FILM CO., LTD. 2006-06-29 US disclosed
US-20060105202-A1 Organic electroluminescent device FUJI PHOTO FILM CO., LTD. 2006-05-18 US disclosed
US-20060099451-A1 Organic electroluminescent device FUJI PHOTO FILM CO., LTD. 2006-05-11 US disclosed
US-20060099450-A1 Organic electroluminescent device FUJI PHOTO FILM CO., LTD. 2006-05-11 US disclosed
EP-1630217-A1 LIGHT-EMITTING DEVICE Takasago International Corporation (JP) 2006-03-01 EP disclosed
EP-1623973-A1 PLATINUM COMPLEX Takasago International Corporation (JP) 2006-02-08 EP disclosed
US-6541490-B1 Treating ischemia or reoxygenation injury; preparation from a bipyridine, a benzeneboronic acid and a manganese salt EUKARION, INC. 2003-04-01 US disclosed
EP-1119573-A2 BIPYRIDINE MANGANESE COMPLEXES EUKARION, INC. (US) 2001-08-01 EP disclosed
US-6177419-B1 ANTIOXIDANT CHELATE COMPOUNDS FOR PREVENTING OXYGEN FREE RADICAL-ASSOCIATED DISEASES IN MAMMALS; NEUROPROTECTANTS, SUPEROXIDE DISMUTASE (SOD), CATALASE (CAT) AND/OR PEROXIDASE (POD) MIMETICS EUKARION, INC. 2001-01-23 US disclosed
WO-2000009512-A2 BIPYRIDINE MANGANESE COMPLEXES EUKARION, INC. (US) 2000-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220344601-A1 Organic Electroluminescent Devices and Metal Complex Compounds EPCAM, TPR, L1CAM IDO1 3025/4885SMN1; SMN2 4551/4885LMNA 2623/4885
US-20190355918-A1 Organic Electroluminescent Devices and Metal Complex Compounds EPCAM, TPR, L1CAM IDO1 3025/4885SMN1; SMN2 4551/4885LMNA 2623/4885
US-10396299-B2 Organic electroluminescent devices and metal complex compounds EPCAM, TPR, L1CAM IDO1 3025/4885SMN1; SMN2 4551/4885LMNA 2623/4885
US-11393989-B2 Organic electroluminescent devices and metal complex compounds EPCAM, TPR, L1CAM IDO1 3025/4885SMN1; SMN2 4551/4885LMNA 2623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.